|
BIOSTEM TECHNOLOGIES INC.
US SYMBOL: BSEM
Last Price: 4.78 | Website | Latest News
Good Morning Ggg,
Make sure BSEM is on your screen today at the Opening Bell! If you haven't yet, read our Full Alert below....
To many of you, Today's New Alert may be a familiar face. In fact, to special some of you, you've probably already reaped some serious GAINS from it!
Operating in the MedTech space with cutting edge regenerative medicine, ROARING REVENUE GROWTH, and a unique Breakout Chart to match...
WE ARE ISSUING AN IMMEDIATE ALERT ON BSEM FOR TODAY!
The future is regenerative medicine and BioStem Technologies (OTC: BSEM) is leading the way with innovation, exploding revenues, and breakthrough achievements!
This growing Medtech company is harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies in advanced wound care. BSEM is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method.
BSEM manufactures perinatal tissue allografts at the highest levels of quality, leveraging their BioREtain method to focus on maintaining natural growth factors and preserving tissue structure.
BSEM's allografts, including VENDAJE®, VENDAJE AC®, VENDAJE OPTIC® and AmnioWrap2TM are trusted by top clinicians across a range of specialties.
So it should come as no wonder why BSEM has seen Revenues EXPLODE and why there's so much talk of a NASDAQ UPLIST....
In just the last year alone, BSEM generated over $301 MILLION DOLLARS in Revenues compared to $16.6 Million the previous year. That's an 1,857% INCREASE!!
Now as compared to 2021 - that's a 6855% REVENUE BOOM in just 4 years!!
Talk about SUCCESS!!
Yet BSEM still trades on the OTC Markets at around a mere $6.00 with over 323% UPSIDE at it's 52 Week High of $28.26.
According to the company, BSEM is currently working through the audit of its historical annual financial statements and pursing uplisting to Nasdaq.
A company with MASSIVE Revenues like this should be trading on the NASDAQ!
So could all of that be about to change? Read on...
BSEM POISED FOR A BOTTOMED CHART BREAKOUT?
Even though BSEM's 2nd Quarter Earnings were phenomenal, the market reacted poorly to some insight from the company about increased competition.
And so BSEM has since found itself near 52 Week Lows with a major chart gap...
The positives here are that BSEM has held this bottomed support since it's sell-off allowing buying volume to come back in and hold it steady.
So it has since developed into a Falling Wedge Pattern...
FALLING WEDGE PATTERN
:max_bytes(150000):strip_icc():format(webp)/dotdash_Final_Wedge_May_2020-02-67d7156b6b40435584b05b73f969181c.jpg) |
When a security's price has been falling over time, a wedge pattern can occur just as the trend makes its final downward move. The trend lines drawn above the highs and below the lows on the price chart pattern can converge as the price slide loses momentum and buyers step in to slow the rate of decline. Before the lines converge, the price may breakout above the upper trend line.
When the price breaks the upper line, the trend is expected to reverse and rise. Traders looking for bullish signals may seek trades that benefit from rising prices. |
BSEM also sits just under the 50 Day Moving Average resistance (blue line) which means a breach through it could confirm a New Bullish Trend!
Not to mention, our MACD Indicator CONFIRMED BULLISH DIVERGENCE and still continues to trend up even while BSEM has traded sideways, indicating growing buying pressure.
So could BSEM "Fill the GAP" and move back to past highs and beyond Tomorrow?
Keep in mind, a return to 52 Week Highs of 28.26 would generate over 491% GAINS!
THE BOTTOM LINE
It's not often we come across a Falling Wedge Pattern. BUT - this is one of the most SOLID Bullish Patterns out there.
And considering that BSEM is seeing Record-Breaking Revenue Growth to the tune of $301 MILLION, yet trades this cheaply on the OTC could mean that brighter days are ahead of us in the near future....
“Uplisting to Nasdaq remains a top priority for BioStem, and with our new CFO onboard, we are evaluating the audit process and refining our strategy to move the uplisting forward. This includes a comprehensive review of BioStem’s operations and associated financials, which is ongoing. Following the finalization of the Form 10, the pathway to uplisting is straightforward. We appreciate the patience and support of our shareholders and look forward to the benefits of listing on a national exchange.” - Jason Matuszewski, Chairman and CEO of BioStem
Keep in mind, BSEM's CEO is also BUYING more shares of BSEM at these low prices!!
Does he know something we don't?
*cough* 491% UPSIDE *cough* 😉😉😉
Needless to say, Bottom-Barrel Breakout situations like this come around often for BSEM and you're going to want to have this one on your radar BEFORE it potentially Uplists to the NASDAQ!
Make sure you put it on your screen RIGHT NOW and
Follow on Twitter for Updates + Play-by-Play!
|
